E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/24/2016 in the Prospect News PIPE Daily.

Marapharm wraps C$1.09 million units placement with C$563,500 tranche

Company sells 5,457,500 units of one share and one warrant at C$0.20

By Devika Patel

Knoxville, Tenn., May 24 – Marapharm Ventures Inc. said it raised C$563,500 in the second and final tranche of a C$1.09 million non-brokered private placement of units. The deal priced for C$1 million on Feb. 29 and raised C$528,000 on April 1.

The company sold 5,457,500 units of one common share and one warrant at C$0.20 per unit on a best-efforts basis. It sold 2.64 million units in the initial tranche and 2,817,500 units in the second tranche.

Each warrant will be exercisable at C$0.40 for one year. The strike price is a 135.29% premium to C$0.17, the Feb. 26 closing share price.

Proceeds will be used for development of the North Las Vegas project, potential licensing investigation and development in Washington state and general corporate purposes.

Based in Vancouver, B.C., the company invests in health and wellness, including medical and recreational marijuana.

Issuer:Marapharm Ventures Inc.
Issue:Units of one common share and one warrant
Amount:C$1,091,500
Units:5,457,500
Price:C$0.20
Warrants:One warrant per unit
Warrant expiration:One year
Warrant strike price:C$0.40
Agent:Non-brokered
Pricing date:Feb. 29
Settlement date:April 1 (for C$528,000), May 24 (for C$563,500)
Stock symbol:CNSX: MDM
Stock price:C$0.17 at close Feb. 26

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.